Serum calcification propensity predicts all-cause mortality in predialysis CKD - Wikidata - wikimedia - TriplyDB

Serum calcification propensity predicts all-cause mortality in predialysis CKD

Serum calcification propensity predicts all-cause mortality in predialysis CKD

http://www.wikidata.org/entity/Q37524150

about

The role of fetuin-A in mineral trafficking and deposition Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability MICS, an easily ignored contributor to arterial calcification in CKD patients.A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum.A current understanding of vascular calcification in CKD.High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.Phosphocalcic Markers and Calcification Propensity for Assessment of Interstitial Fibrosis and Vascular Lesions in Kidney Allograft Recipients.Calcification Propensity and Survival among Renal Transplant Recipients.Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease.Fetuin-A: a novel link between obesity and related complications.Public health relevance of drug-nutrition interactions.The Role of Secondary Calciprotein Particles in the Mineralisation Paradox of Chronic Kidney Disease.The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease.Inflammation and premature aging in advanced chronic kidney disease.A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma.Serum Calcification Propensity Is a Strong and Independent Determinant of Cardiac and All-Cause Mortality in Kidney Transplant Recipients.Worsening calcification propensity precedes all-cause and cardiovascular mortality in haemodialyzed patients.Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial.Calcification Propensity of Serum is Independent of Excretory Renal Function.Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.Hope for CKD-MBD Patients: New Diagnostic Approaches for Better Treatment of CKD-MBD.A rapid and sustained improvement of calcification propensity score (serum T50 ) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate.Novel treatment strategies for chronic kidney disease: insights from the animal kingdom.Expanded Haemodialysis Therapy of Chronic Haemodialysis Patients Prevents Calcification and Apoptosis of Vascular Smooth Muscle Cells in vitro.High cut-off dialysis in chronic haemodialysis patients reduces serum procalcific activity.Calciprotein particles as potential etiologic agents of idiopathic preterm birth.Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB.Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial.Is there a role for newer biomarkers in chronic kidney disease-mineral and bone disorder management?Biomarkers Associated with Vascular Calcification in Peritoneal Dialysis.Biological and Clinical Effects of Calciprotein Particles on Chronic Kidney Disease-Mineral and Bone Disorder.Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification.Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism.Molecular Mechanisms Underlying Accelerated Aging by Defects in the FGF23-Klotho System.Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity Phosphate, Calcification in Blood, and Mineral Stress: The Physiologic Blood Mineral Buffering System and Its Association with Cardiovascular Risk

P2860

Q27021447-1FD8494B-A365-417B-850F-34B4A1639F64 Q28081407-68EB08A7-75DE-445E-89AF-350074102138 Q30249410-D938AD64-7759-4426-99A1-4FA77B51038E Q33916132-942E1C51-C95E-45E5-B036-8CAA4BEF9686 Q34355897-1008EFBC-EBBE-4157-BD14-68B6716B1E05 Q35985639-40A9683B-3FF5-4D48-A669-83C6AC29EC9F Q36236289-D57DA688-E513-4F74-9B25-C8BC3C0219CA Q36417860-38AFD900-CCC1-4CC2-9EA6-C0E3B324DC24 Q37271191-5F7C246C-2EFA-445D-9B11-50F98DE5C9D9 Q38282015-B078286D-C093-4962-AA98-C5B1C832C09E Q38651214-C846B116-3498-47FA-995A-855466F9BADD Q38693604-37CB9683-0851-484F-837F-9D36B3EEDA93 Q38711321-DA3DFAA3-7B50-433B-9A4A-75A8188E17D0 Q38837072-7F5C4F58-5738-47B5-A0D5-9439416084DE Q39309490-A1919D84-DD9E-4553-8183-A252C1F5C65C Q41191725-02806C4B-113E-465C-8BBB-B11DD2FFC540 Q41353160-3A54CB45-A9EC-4741-A77F-A75A0016C739 Q42684103-0CBDC3DC-2188-48D9-919D-BD4F7E05B5DE Q43692218-E46F20FA-52E5-454E-80DE-68CB446F6A0B Q47100824-D8FF5770-7632-4FB5-A649-29D552E5F211 Q47103592-75980F49-1254-448E-B87E-EFBA21BC2A7F Q47549484-627ACAB8-DD9C-4A63-91FD-4307F5D9B7B3 Q47571217-24FC0A3E-981B-4C26-BB09-FC1D8844073B Q48252688-5CECCBBA-D95B-4BB8-9D12-3F5F9382F4D0 Q50051044-330F9717-04A9-4B97-8078-E355F274C585 Q50149505-D16576E7-2A2B-4173-92B2-D3D961B5A313 Q50234694-7124C1F4-23FF-4965-9B8E-748DFB8957E7 Q51334502-EA21194C-7371-4CC6-95EC-4834D5065A95 Q52719479-D7E9B215-59EB-44A5-B0CA-2BC302859BD0 Q53307902-4524520C-4536-4AFA-B3F0-FF71CD081C4F Q53342879-6C871EE0-0E2F-40A0-A4DA-C9AB744438BF Q53378011-909EC525-6640-4872-AF25-8ABA24FA026B Q54961270-7E529B85-558E-4A56-8BC6-025CBF232791 Q55098165-2AE29399-2730-4D9D-99BB-2AE4A5E00495 Q55109311-8AFD1C74-A266-49CF-9639-88E8C1028985 Q55360714-FB16B4EE-5456-4587-85D7-A39FC409CC38 Q58721207-973B9BD2-43C5-45CF-8976-BE50BCEA65D5 Q58764852-197187CA-081D-4DA7-BC50-C6F009F8B8C0 Q58770132-CB55D7FD-A5E1-4E10-9D42-2FC24B2C6CFD

P2860

Serum calcification propensity predicts all-cause mortality in predialysis CKD

http://www.wikidata.org/entity/Q37524150

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum calcification propensity predicts all-cause mortality in predialysis CKD

@en

Serum calcification propensity predicts all-cause mortality in predialysis CKD.

@nl

type

label

Serum calcification propensity predicts all-cause mortality in predialysis CKD

@en

Serum calcification propensity predicts all-cause mortality in predialysis CKD.

@nl

prefLabel

Serum calcification propensity predicts all-cause mortality in predialysis CKD

@en

Serum calcification propensity predicts all-cause mortality in predialysis CKD.

@nl

P1433

Q37524150-6C6F1D51-1135-4A0A-98DE-5256AFCABD0F

P1476

Q37524150-F0CA0C00-2981-4DB9-BF0A-ADB240BA59FF

P2093

Q37524150-2AC9A8DA-F1F6-4D39-82BB-C613C07074CD

Q37524150-2B1511F0-46CE-43DF-8196-BEE760952D92

Q37524150-2B4613C7-C078-44C8-95B5-85F0BDD5613F

Q37524150-2CA436A4-8E3B-499F-BED6-6E18F5266542

Q37524150-372638D3-3CE2-4A7C-88B7-C04F7EAB7631

Q37524150-9BE26436-C17A-406E-8CD8-DA2582702D67

Q37524150-C00C73DA-2B4E-4E0B-A8BE-D1084F4CDFA8

P2860

Q37524150-0BE527DE-D075-43C1-97C2-0113D0CE4506

Q37524150-19345839-6F35-4415-8E64-49921A36A52F

Q37524150-2A647B89-A31B-4069-AB52-0ED50C7808C6

Q37524150-2F5C1D1F-AC30-4102-A862-171CE3D57331

Q37524150-3080E2C9-2AA9-4709-9B8A-1D4A62479018

Q37524150-41574C37-6871-484C-93A2-9A6BAE3A545A

Q37524150-436ED469-F52A-438A-BFC3-93246195D428

Q37524150-462CE090-2F5B-4C69-868C-958A60A85D64

Q37524150-5436DA19-66C3-435A-8A5E-188457B0A31C

Q37524150-7D4C3767-0C3E-4CA1-96F9-464B9E200E34

P304

Q37524150-0498E0F2-E7CD-48C9-83BC-F5C568018195

P31

Q37524150-244ED4ED-F81B-4B4C-BC97-42B3E7909C8E

P356

Q37524150-22E0FB9F-6172-4519-A189-B6EAAE4B3F4C

P433

Q37524150-16ADB7D9-FD00-40AB-BB1A-EC6C1B710360

P478

Q37524150-D165B02C-C009-474F-8A72-A9F33E548C0F

P50

Q37524150-286EC8A2-4A90-4E96-A181-E0088A030A35

Q37524150-799DF230-39EB-4476-BF17-6D0298529FA0

Q37524150-E42D3689-B2B0-42BE-80EF-523D7C824EEC

P577

Q37524150-2539C710-07B7-4B7A-8A41-546ACCAFC887

P698

Q37524150-7CD43742-3774-4F06-B257-ED17E97FBB8D

P932

Q37524150-3A1B83C2-3CF7-47F8-A2BA-3770FEA629E5

P356

P1433

Journal of the American Society of Nephrology

P1476

Serum calcification propensity predicts all-cause mortality in predialysis CKD

@en

P2093

Andreas Pasch

http://www.w3.org/2001/XMLSchema#string

Chakravarthi Rajkumar

http://www.w3.org/2001/XMLSchema#string

Edward R Smith

http://www.w3.org/2001/XMLSchema#string

Emma Bodenham

http://www.w3.org/2001/XMLSchema#string

Lawrence P McMahon

http://www.w3.org/2001/XMLSchema#string

Martin L Ford

http://www.w3.org/2001/XMLSchema#string

Stefan Farese

http://www.w3.org/2001/XMLSchema#string

P2860

Arterial calcification in chronic kidney disease: key roles for calcium and phosphate

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Generation and application of data on biological variation in clinical chemistry.

Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults.

Expert consensus document on arterial stiffness: methodological issues and clinical applications.

Fetuin-mineral complex reflects extraosseous calcification stress in CKD

Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage.

Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.

Arterial aging: pathophysiological principles.

Arterial Stiffness and Wave Reflection: Biomarkers of Cardiovascular Risk.

P304

339-348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2013060635

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Laurie A Tomlinson

P577

2013-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24179171

http://www.w3.org/2001/XMLSchema#string

P932

3904573

http://www.w3.org/2001/XMLSchema#string